Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

IMATINIB Plus Hydroxyurea in the Treatment of Recurrent or Progressive Meningiomas: a Randomized Phase II Study

NCT00904735 is registered in ClinicalTrials.gov with Istituto Scientifico H. San Raffaele as lead sponsor.

NCT NCT00904735
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00904735 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
IMATINIB Plus Hydroxyurea in the Treatment of Recurrent or Progressive Meningiomas: a Randomized Phase II Study
Lead sponsor
Istituto Scientifico H. San Raffaele
Phase
Phase 2
Overall status
Unknown status
Start date
June 30, 2009
Completion date
Not reported
Enrollment
76 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

brain and central nervous system tumors